Maliki Ankavay

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Hepatitis B Virus

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Noémie Oechslin, Nathalie Da Silva, Maliki Ankavay, Darius Moradpour, Jérôme Gouttenoire
A genome-wide CRISPR/Cas9 screen identifies a role for Rab5A and early endosomes in hepatitis E virus replication. Proceedings of the National Academy of Sciences of the United States of America 120 (52) (2023)
Noémie Oechslin, Nathalie Da Silva, Maliki Ankavay, Darius Moradpour, Jérôme Gouttenoire
A genome-wide CRISPR/Cas9 screen identifies a role for Rab5A and early endosomes in hepatitis E virus replication. Proceedings of the National Academy of Sciences of the United States of America 120 (52) (2023)
Noémie Oechslin, Nathalie Da Silva, Maliki Ankavay, Darius Moradpour, Jérôme Gouttenoire
A genome-wide CRISPR/Cas9 screen identifies a role for Rab5A and early endosomes in hepatitis E virus replication. Proceedings of the National Academy of Sciences of the United States of America 120 (52) (2023)
Noémie Oechslin, Nathalie Da Silva, Maliki Ankavay, Darius Moradpour, Jérôme Gouttenoire
A genome-wide CRISPR/Cas9 screen identifies a role for Rab5A and early endosomes in hepatitis E virus replication. Proceedings of the National Academy of Sciences of the United States of America 120 (52) (2023)
Noémie Oechslin, Nathalie Da Silva, Maliki Ankavay, Darius Moradpour, Jérôme Gouttenoire
A genome-wide CRISPR/Cas9 screen identifies a role for Rab5A and early endosomes in hepatitis E virus replication. Proceedings of the National Academy of Sciences of the United States of America 120 (52) (2023)